App-Quantinova.ai

Global Overview of the Management of Acute CHOLEcystitis during the COVID-19 Pandemic: The CHOLECOVID Study

H.V. Spiers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence

S. Dreyer - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Impact of Lymph Node Ratio on Survival in the Histopathological Subtypes of Resected Ampullary Cancer: A Retrospective International Multicenter Cohort Study

D.H. Lemmers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Ampullary carcinoma

N/A

Clinical Outcomes of Adult Living Donor Liver Transplantation in High MELD Recipients: A Systematic Review and Meta-Analysis

J. Kumar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Resected Perihilar Cholangiocarcinoma, the ENS-CCA Registry

L.E. Nooijen - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Advanced biliary tract carcinoma

N/A

Disappearing Colorectal Liver Metastases in the Era of State-of-The-Art Triple-Modality Diagnostic Imaging with CT, MR and FDG-PET

A. Tufo - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Impact of the Extent of Resection of Neuroendocrine Liver Metastases on Survival: A Systematic Review and Meta-Analysis

R. KULKARNI - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Secondary liver cancer

N/A

Peri-Operative Thrombophilia in Patients Undergoing Liver Resection for Colorectal Metastases

C. Walsh - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

R1 Resection Margin Status for Colorectal Liver Metastases Impacts Survival But Not because of Marginal Recurrence

J.A. Helliwell - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Management of Colorectal Cancer with Synchronous Liver Metastases: The Final Results of the Cosmic Inception Cohort Study

A.K. Chan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Management of Colorectal Cancer with Synchronous Liver Metastases: A Systematic Review of National and International Clinical Guidelines (CoSMIC-G)

A.K. Chan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Potential Clinical Utility of Near Infrared Fluorescence Imaging to Detect Colorectal Liver Metastases during Hepatectomy: Single UK Centre Experience

I. Patel - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Prognostic Role of Circulating Tumor Cells in Resectable Colorectal Liver Metastases

M. ROY - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

The Dilemma of the Disappeared Colorectal Liver Metastasis: Systematic Review of the Systematic Reviews

A. Nassar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Liver First Approach for Synchronous Colorectal Liver Metastasis: Is First Approach the Best Approach?

S. Shankar - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Long Term Follow up Strategy for CRLM Following Liver Resection

I. Rajput - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Outcomes of Resection for Colorectal Liver Metastases in Patients with Early Onset Colorectal Cancer

Z.A. Khan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Colorectal Cancer and Synchronous Liver-Limited Metastases: An Individual Case-Based Qualitative Study (CoSMIC-Q)

A.K. Chan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Tumour Sidedness and KRAS Mutation Status in the Management of Colorectal Cancer with Synchronous Liver Metastases: A Subgroup Analysis of the Cosmic Cohort

A.K. Chan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

N/A

Prognostic Factors in Patients with Breast Cancer Liver Metastases (BCLM) Undergoing Liver Resection: Systematic Review and Meta-Analysis

F. Galiandro - International Hepato-Pancreato-Biliary Association (IHPBA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Secondary liver cancer

N/A

Filters

45280 Abstracts